Premium Nahrungsergänzungsmittel | artgerecht

Bronchopneumonia: Causes, Symptoms and Treatment

Bronchopneumonia is an inflammatory lung disease affecting the bronchi and lung tissue simultaneously. It commonly occurs in young children and elderly individuals.

Regular tips about health Regular tips about health

Things worth knowing about "Bronchopneumonia"

Bronchopneumonia is an inflammatory lung disease affecting the bronchi and lung tissue simultaneously. It commonly occurs in young children and elderly individuals.

What is Bronchopneumonia?

Bronchopneumonia is a type of pneumonia in which inflammation affects the small airways (bronchi and bronchioles) as well as the surrounding lung tissue (alveoli) at the same time. Unlike lobar pneumonia, which involves an entire lobe of the lung, bronchopneumonia presents in a patchy distribution and can affect both lungs simultaneously. It is one of the most common infectious diseases of the lower respiratory tract.

Causes

Bronchopneumonia is most commonly triggered by pathogens that enter the lungs through the airways. The most frequent causes include:

Bacteria: Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae
Viruses: Influenza viruses, Respiratory Syncytial Virus (RSV), SARS-CoV-2
Fungi: Candida or Aspergillus species (especially in immunocompromised individuals)
Aspiration: Inhalation of gastric contents or foreign bodies

Risk factors include a weakened immune system, advanced age, premature birth, pre-existing lung conditions, prolonged bed rest, and prior upper respiratory tract infections.

Symptoms

Symptoms can vary depending on the age and general health of the affected person. Typical signs include:

Fever, often with chills
Cough, frequently producing yellowish-green or blood-tinged mucus
Rapid breathing (tachypnea) and shortness of breath
Chest pain when breathing
General weakness and fatigue
In infants and young children: nasal flaring, chest wall retractions, poor feeding
In older adults: atypical symptoms such as confusion or loss of appetite without obvious fever

Diagnosis

The diagnosis of bronchopneumonia is established through a combination of clinical assessment and diagnostic investigations:

Physical examination: Auscultation of the lungs, percussion findings
Chest X-ray: Detection of patchy infiltrates in both lungs
Blood tests: Elevated inflammatory markers (CRP, white blood cell count, procalcitonin)
Pathogen identification: Blood culture, sputum culture, or throat swab
Pulse oximetry: Measurement of blood oxygen saturation
CT scan of the chest: Used in unclear or severe cases

Treatment

Treatment depends on the causative pathogen, the severity of the illness, and the overall condition of the patient.

Medical Treatment

Antibiotics: For bacterial infections, e.g., amoxicillin, clarithromycin, or cephalosporins depending on the pathogen and resistance profile
Antiviral agents: Oseltamivir may be used in cases of influenza
Antipyretics and analgesics: For fever and pain relief (e.g., paracetamol, ibuprofen)
Mucolytics: To help loosen and clear mucus from the airways

Supportive Measures

Adequate fluid intake
Rest and physical recovery
Supplemental oxygen if blood oxygen levels are low
Breathing exercises and physiotherapy to aid mucus clearance
In severe cases: inpatient or intensive care management

Prognosis and Prevention

With timely treatment, the prognosis for bronchopneumonia is generally favorable. However, high-risk groups such as the elderly, premature infants, and immunocompromised individuals may experience severe or life-threatening illness. Prevention strategies include vaccination against pneumococcal disease and influenza, good hand hygiene, and avoiding smoking.

References

World Health Organization (WHO): Pneumonia Fact Sheet. Geneva, 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/pneumonia
Mandell LA, Wunderink RG et al.: Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 2007; 44(S2): S27-S72.
Lim WS et al.: BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009; 64(Suppl 3): iii1-iii55.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.